![Results of a Six-Month, Randomized, Controlled, Phase 3 Trial Comparing the Efficacy and Safety Of Probuphine™ to Placebo Implants, and Suboxone® for Opioid Addiction Results of a Six-Month, Randomized, Controlled, Phase 3 Trial Comparing the Efficacy and Safety Of Probuphine™ to Placebo Implants, and Suboxone® for Opioid Addiction](https://d1io3yog0oux5.cloudfront.net/_3778185ac203a62d977c755cd2271aac/titanpharm/db/341/1103/pdf_thumbnail.jpg)
Results of a Six-Month, Randomized, Controlled, Phase 3 Trial Comparing the Efficacy and Safety Of Probuphine™ to Placebo Implants, and Suboxone® for Opioid Addiction
Presented by Titan Pharmaceuticals at the 13th annual meeting of International Society of Addiction Medicine (ISAM), Oslo, Norway, September 2011.